- Home
- APGE vs CPRX Comparison
APGE vs CPRX Comparison
Compare APGE & CPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APGE
- CPRX
- Stock Information
- Founded
- APGE 2022
- CPRX 2002
- Country
- APGE United States
- CPRX United States
- Employees
- APGE N/A
- CPRX N/A
- Industry
- APGE Biotechnology: Biological Products (No Diagnostic Substances)
- CPRX Biotechnology: Pharmaceutical Preparations
- Sector
- APGE Health Care
- CPRX Health Care
- Exchange
- APGE Nasdaq
- CPRX Nasdaq
- Market Cap
- APGE 2.4B
- CPRX 2.6B
- IPO Year
- APGE 2023
- CPRX 2006
- Fundamental
- Price
- APGE $52.11
- CPRX $20.80
- Analyst Decision
- APGE Strong Buy
- CPRX Strong Buy
- Analyst Count
- APGE 7
- CPRX 5
- Target Price
- APGE $93.14
- CPRX $33.20
- AVG Volume (30 Days)
- APGE 680.5K
- CPRX 1.6M
- Earning Date
- APGE 11-11-2025
- CPRX 11-05-2025
- Dividend Yield
- APGE N/A
- CPRX N/A
- EPS Growth
- APGE N/A
- CPRX 183.96
- EPS
- APGE N/A
- CPRX 1.65
- Revenue
- APGE N/A
- CPRX $558,499,000.00
- Revenue This Year
- APGE N/A
- CPRX $16.51
- Revenue Next Year
- APGE N/A
- CPRX $9.58
- P/E Ratio
- APGE N/A
- CPRX $12.63
- Revenue Growth
- APGE N/A
- CPRX 28.55
- 52 Week Low
- APGE $26.20
- CPRX $19.05
- 52 Week High
- APGE $63.50
- CPRX $26.58
- Technical
- Relative Strength Index (RSI)
- APGE 84.17
- CPRX 55.73
- Support Level
- APGE $39.21
- CPRX $20.34
- Resistance Level
- APGE $40.48
- CPRX $21.22
- Average True Range (ATR)
- APGE 2.26
- CPRX 0.62
- MACD
- APGE 1.18
- CPRX 0.12
- Stochastic Oscillator
- APGE 92.22
- CPRX 56.90
About APGE Apogee Therapeutics Inc.
Apogee Therapeutics Inc is a biotechnology company seeking to develop differentiated biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), and related inflammatory and immunology (I&I) indications with high unmet need. Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating antibody engineering to optimize half-life and other properties.
About CPRX Catalyst Pharmaceuticals Inc.
Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing, developing therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers three drug products, FIRDAPSE (amifampridine), FYCOMPA (perampanel), and AGAMREE (vamorolone).